The potential autocrine/paracrine roles of ghrelin and its receptor in hormone-dependent cancer
Authors:
- Penny L. JefferyPJPenny L. Jeffery
- Adrian C. HeringtonAHAdrian C. Herington
- Lisa K. ChopinLCLisa K. Chopin
- 1 April 2003
- journal article
- review article
- Published by Elsevier in Cytokine & Growth Factor Reviews
- Vol. 14 (2) , 113-122
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- Ghrelin-Producing Endocrine Tumors of the Stomach and IntestineThe Journal of Clinical Endocrinology & Metabolism, 2001
- Substantial Production of Ghrelin by a Human Medullary Thyroid Carcinoma Cell LineThe Journal of Clinical Endocrinology & Metabolism, 2001
- Antagonists of Growth Hormone-Releasing Hormone and Somatostatin Analog RC-160 Inhibit the Growth of the OV-1063 Human Epithelial Ovarian Cancer Cell Line Xenografted into Nude MiceThe Journal of Clinical Endocrinology & Metabolism, 2001
- Ghrelin and Des-acyl Ghrelin: Two Major Forms of Rat Ghrelin Peptide in Gastrointestinal TissueBiochemical and Biophysical Research Communications, 2000
- Antagonists of growth hormone-releasing hormone (GH-RH) inhibit in vivo proliferation of experimental pancreatic cancers and decrease IGF-II levels in tumoursEuropean Journal of Cancer, 2000
- Cloning and Characterization of the 5′-Flanking Region of the Human Growth Hormone Secretagogue Receptor GeneJournal of Biological Chemistry, 1998
- Increased incidence of neoplasia in patients with pituitary adenomasClinical Endocrinology, 1998
- Circulating concentrations of insulin-like growth factor I and risk of breast cancerThe Lancet, 1998
- Growth hormone directly affects the function of the different lobes of the rat prostateEndocrinology, 1995
- Effect of Tamoxifen on Serum Insulinlike Growth Factor I Levels in Stage I Breast Cancer PatientsJNCI: Journal of the National Cancer Institute, 1990